Locations
Palo Alto, CA, USA · San Francisco, CA, USA
industry
Biotechnology
Size
11-50 employees
Stage
Other
founded in
2020
We are focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel. With data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies. Our drug-gene atlas maps molecular structure and drug action to the whole cell transcriptome, revealing therapeutic candidates that rebalance gene expression to treat disease. Our proprietary Artificial Intelligence modeling suite, Conductor AI, used our drug-gene atlas to discover and predict the effects of new drugs at transcriptome scale.
Is this your company?
Something looks off?